Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Completed · Phase 3

Conditions studied: Pain, Cancer

In brief

The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl when used long-term to relieve breakthrough pain in opioid tolerant cancer patients.

Key facts

Study ID
NCT00105287
Run by
Cephalon
People needed
100
Starts
2005-01-01
Expected to finish
2007-09-01
Last updated by the study team
2014-05-09

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.